We first examined the expression of Mir100hg in lung cancer stem cells (LLC-SD) versus non-stemness lung cancer cells (LLC), and we found that Mir100hg was overexpressed in LLC-SD compared to that in LLC cells (Fig. 2D). The gene discussed is MIR100HG; the disease is lung cancer.